Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01892423 · ClinicalTrials.gov registry record · NA
Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
NCT01892423: Completed NA study, sponsored by Galderma R&D.
NCT01892423 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 146 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01892423, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
Study Summary
Human repeat insult patch test to assess the potential for Cetaphil Moisturizing Lotion Daily Advance to induce sensitization to the skin
Primary Outcome
all patients will be assessed at 14 visits for redness (erythema), spreading, weeping, papules, vesicles, and bullae at application site
Interventions
- OTHER Cetaphil Moisturizing Lotion Daily Advance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2006-08 |
| Phase | NA |
What the finished NCT01892423 record still lists
NCT01892423 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Cetaphil Moisturizing Lotion Daily Advance is the first listed.
NCT01892423 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01892423 about?
NCT01892423 is a clinical study titled "Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion". Human repeat insult patch test to assess the potential for Cetaphil Moisturizing Lotion Daily Advance to induce sensitization to the skin
What is the current status of trial NCT01892423?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2006-08.
What interventions are being tested in trial NCT01892423?
The interventions under investigation include: Cetaphil Moisturizing Lotion Daily Advance (OTHER).
Who is sponsoring clinical trial NCT01892423?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01892423's enrollment target sits among peer trials
146 704th of 2000 higher than 1,296 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia